168 related articles for article (PubMed ID: 36015309)
1. Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood-Brain Barrier.
Kurosawa T; Tega Y; Uchida Y; Higuchi K; Tabata H; Sumiyoshi T; Kubo Y; Terasaki T; Deguchi Y
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015309
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
3. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
4. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
5. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
[TBL] [Abstract][Full Text] [Related]
6. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
7. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
[TBL] [Abstract][Full Text] [Related]
9. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
10. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
12. Pyrilamine-sensitive proton-coupled organic cation (H
Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.
Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S
Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line.
Smirnova M; Goracci L; Cruciani G; Federici L; Declèves X; Chapy H; Cisternino S
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213988
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.
Kadoguchi M; Arakawa H; Honda R; Hotta K; Shirasaka Y; Deguchi Y; Tamai I
Pharm Res; 2022 Jul; 39(7):1549-1559. PubMed ID: 35314999
[TBL] [Abstract][Full Text] [Related]
16. Cocktail-Dosing Microdialysis Study to Simultaneously Assess Delivery of Multiple Organic-Cationic Drugs to the Brain.
Kitamura A; Okura T; Higuchi K; Deguchi Y
J Pharm Sci; 2016 Feb; 105(2):935-940. PubMed ID: 26554532
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cell-Surface Proteins Endocytosed by Human Brain Microvascular Endothelial Cells In Vitro.
Ito S; Oishi M; Ogata S; Uemura T; Couraud PO; Masuda T; Ohtsuki S
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585920
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.
Chapy H; Goracci L; Vayer P; Parmentier Y; Carrupt PA; Declèves X; Scherrmann JM; Cisternino S; Cruciani G
Br J Pharmacol; 2015 Oct; 172(20):4888-904. PubMed ID: 26220580
[TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]